Postpartum Readmissions Among Women With Diabetes.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 7 12 2019
medline: 16 4 2020
entrez: 7 12 2019
Statut: ppublish

Résumé

To estimate whether women with diabetes are at risk for 60-day postpartum readmissions and associated complications. The Nationwide Readmissions Database from 2010 to 2014 was analyzed to determine risk for 60-day postpartum readmissions among women with type 1 diabetes mellitus (DM), type 2 DM, gestational diabetes mellitus (GDM), and unspecified DM compared with women with no diabetes. Secondary outcomes included evaluating risk for overall severe maternal morbidity during readmissions, as well as wound complications, acute diabetic complications such as diabetic ketoacidosis, venous thromboembolism, and hypertensive diseases of pregnancy. Billing data were used to ascertain both exposures and outcomes. Adjusted log-linear regression models including demographic, hospital, medical and obstetric, and hospital factors were performed with adjusted risk ratios (aRRs) and with 95% Cis as measures of association. Of an estimated 15.7 million delivery hospitalizations, 1.1 million occurred among women with diabetes, of whom 3.2% had type 1 DM, 9.1% type 2 DM, 86.6% GDM, and 1.1% unspecified diabetes. Compared with women without diabetes (1.5% risk for readmission), risk for readmission was significantly higher for women with type 1 DM (4.4%), unspecified diabetes (4.0%), type 2 DM (3.9%), and GDM (2.0%) (P<.01). After adjusting for hospital, demographic, medical, and obstetric risk factors, type 1 DM (aRR 1.77, 95% CI 1.69-1.87), type 2 DM (aRR 1.46, 95% CI 1.42-1.51), unspecified (aRR 1.73, 95% CI 1.59-1.89) and gestational diabetes (aRR 1.16, 95% CI 1.14-1.17) retained increased risk. Among women with diabetes public insurance, lower ZIP code income quartiles, and hospitals with high safety net burdens were associated with higher risk for readmission. In both unadjusted and adjusted analyses, all diabetes diagnoses were associated with readmissions for wound complications, hypertensive diseases of pregnancy, and severe maternal morbidity. Although overall risk for readmission is low, pregnancies complicated by pregestational diabetes in particular are at increased risk. Women in this high-risk group should receive coordinated care and be monitored closely in the postpartum period.

Identifiants

pubmed: 31809421
doi: 10.1097/AOG.0000000000003551
pmc: PMC6923572
mid: NIHMS1539512
pii: 00006250-202001000-00012
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-89

Subventions

Organisme : NICHD NIH HHS
ID : K08 HD082287
Pays : United States

Références

Diabet Med. 2015 Oct;32(10):1361-7
pubmed: 25865087
World Neurosurg. 2018 Nov;119:e284-e293
pubmed: 30055361
Diabet Med. 2001 Jul;18(7):573-7
pubmed: 11553188
J Clin Transl Endocrinol. 2017 Apr 08;8:29-34
pubmed: 29067256
Matern Child Health J. 2008 Jul;12(4):469-77
pubmed: 17690963
J Clin Med Res. 2017 Jan;9(1):35-39
pubmed: 27924173
Am J Obstet Gynecol. 2016 Jul;215(1):113.e1-113.e10
pubmed: 27829570
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
BMJ Open Diabetes Res Care. 2019 Apr 8;7(1):e000621
pubmed: 31114699
Am J Obstet Gynecol. 2009 Apr;200(4):365.e1-8
pubmed: 18691691
Diabetes Care. 1996 Oct;19(10):1067-74
pubmed: 8886551
Am J Manag Care. 2010 Oct;16(10):760-7
pubmed: 20964472
Intern Med J. 2005 May;35(5):296-9
pubmed: 15845113
JAMA Surg. 2016 Feb;151(2):120-8
pubmed: 26466334
Am J Obstet Gynecol. 2018 Oct;219(4):401.e1-401.e14
pubmed: 30017675
Obstet Gynecol. 2018 Sep;132(3):784-785
pubmed: 30134408
Diabetol Metab Syndr. 2012 Sep 11;4(1):41
pubmed: 22964143
Diabetes Care. 2010 Apr;33(4):768-73
pubmed: 20067968
Obstet Gynecol. 2019 Apr;133(4):712-719
pubmed: 30870276

Auteurs

Mirella Mourad (M)

Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Science, and the Division of Endocrinology, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH